“Comprehensive analysis of a NAD+ metabolism-derived gene signature to predict the prognosis and immune landscape in endometrial cancer” (2024) Biomolecules and Biomedicine, 24(2), pp. 346–359. doi:10.17305/bb.2023.9489.